Corona virus Preparedness & Response Supplemental Appropriations Act HR 6064

On 3/06/20 the President signed the Coronavirus Preparedness & Response Supplemental Appropriations Act (HR 6064), a $8.3 billion supplemental spending package. The bill designates $1.05 billion for grants to state and local governments and allows funds to be used to reimburse state and local costs already incurred. https://www.congress.gov/116/bills/hr6074/BILLS-116hr6074enr.pdf. Highlights:

  • Appropriates $2.2 billion to the Centers for Disease Control and Prevention (CDC) within the Department of Health and Human Services (HHS) to prevent, prepare for, and respond to the coronavirus, domestically or internationally (Title III).
  • Specifies that of the funding appropriated to the CDC, $950 million must be used for grants to or cooperative agreements with states, localities, territories, and tribal organizations for epidemiology, laboratory capacity, infection control, mitigation, communications, to carry out surveillance, and other preparedness and response activities (Title III).
  • Appropriates $61 million to the Food and Drug Administration within HHS to prevent, prepare for, and respond to the coronavirus, domestically or internationally, including the development of necessary medical countermeasures and vaccines, manufacturing for medical products, and the monitoring of medical product supply chains (Title I).
  • Appropriates $20 million to the Disaster Loans Program Account within the Small Business Administration for the cost of direct loans to make economic injury disaster loans in response to the coronavirus (Title II).
  • Appropriates $836 million to the National Institute of Allergy and Infectious Diseases within the National Institutes of Health (Title III).
  • Appropriates $3.1 billion to the Public Health and Social Services Emergency Fund within the Office of the Secretary to prevent, prepare for, and respond to the coronavirus, including the development of countermeasures and vaccines, prioritizing platform-based technologies with US-based manufacturing capabilities, and the purchase of vaccines, therapeutics, diagnostics, medical supplies, and medical surge capacity (Title III).
  • Requires the HHS Secretary to purchase vaccines in response to an outbreak or pandemic related to coronavirus, and must be purchased in accordance with Federal Acquisition Regulation guidance on fair and reasonable pricing (Title III).
  • Appropriates $435 million to Bilateral Economic Assistance to global health programs to prevent, prepare for, and respond to coronavirus (Title IV).
  • Authorizes the HHS Secretary to temporarily waive certain requirements pertaining to telehealth services during the emergency period to a Medicare recipient by a qualified provider using a telephone if it has audio and video capabilities that are used for two-way, real-time communication (Division B, Sec. 102).

About Us

Videos

Play Video
Play Video
Play Video
Play Video
Copyright @ 2020